beta NGF (Apollo Life Sciences)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namebeta NGF (Apollo Life Sciences)
Drug Alias Namebeta NGF + molecular shuttle (Apollo Life Sciences)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionNerve growth factor receptors agonists
TargetsNerve growth factor receptors
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesApollo Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApollo Life Sciences
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A